Ningbo David Medical Device Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Zaihong Chen
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | no data |
| CEO ownership | 45.8% |
| Management average tenure | no data |
| Board average tenure | 5.2yrs |
Recent management updates
Recent updates
Ningbo David Medical Device's (SZSE:300314) Shareholders Have More To Worry About Than Only Soft Earnings
Oct 30
Earnings Tell The Story For Ningbo David Medical Device Co., Ltd. (SZSE:300314) As Its Stock Soars 28%
Sep 27Even With A 27% Surge, Cautious Investors Are Not Rewarding Ningbo David Medical Device Co., Ltd.'s (SZSE:300314) Performance Completely
May 22Weak Statutory Earnings May Not Tell The Whole Story For Ningbo David Medical Device (SZSE:300314)
Apr 26Ningbo David Medical Device Co., Ltd.'s (SZSE:300314) Shares Leap 31% Yet They're Still Not Telling The Full Story
Mar 06CEO
Zaihong Chen (55 yo)
no data
Tenure
CN¥789,500
Compensation
Mr. Zaihong Chen serves as Chairman of Board at Ningbo David Medical Device Co., Ltd. and serves as its General Manager.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| GM & Chairman | no data | CN¥789.50k | 45.81% CN¥ 1.6b | |
| CFO, Secretary & Director | 5.2yrs | CN¥379.20k | 0.34% CN¥ 12.1m | |
| Deputy GM & Non-Independent Director | 14.3yrs | CN¥378.20k | 0.30% CN¥ 10.6m | |
| Vice Chairman | no data | no data | 20.25% CN¥ 723.8m | |
| Non-Independent Director | 5.2yrs | CN¥500.80k | no data | |
| Non-Independent Director | 14.3yrs | CN¥207.30k | no data | |
| Supervisor | 14.3yrs | no data | no data | |
| Independent Director | 2.1yrs | CN¥11.40k | no data | |
| Supervisor | 4.6yrs | no data | no data | |
| Chairman of the Supervisory Board | 14.3yrs | no data | no data | |
| Independent Director | 2.1yrs | no data | no data | |
| Independent Director | 2.1yrs | CN¥11.40k | no data |
5.2yrs
Average Tenure
52yo
Average Age
Experienced Board: 300314's board of directors are considered experienced (5.2 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/20 08:54 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Ningbo David Medical Device Co., Ltd. is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Sherry Ye | China Stock Investment Research Co. Ltd. (GZ500..com) |
| Weina Jiang | Everbright Securities Co. Ltd. |
| Lijun Huang | Shenwan Hongyuan Securities |